This study identified alterations in gut microbiota composition, microbial metabolic activity, melatonergic pathway, and intestinal permeability in hormone receptor-positive (HR+) breast cancer (BC) patients compared to healthy controls. This evidence concerns the gene NR4A1 and breast cancer.